Epidermal growth factor receptor (EGFR) is the most common targetable driver gene, with mutation incidence of up to 60% in Asian NSCLC populations, which is significantly higher than that in Western populations (10–15%) [3,4]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.